Thursday, March 30, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosurveillance

Q Fever Endocarditis and C. burnetii Infections in Greece

by Global Biodefense Staff
September 7, 2020
Q Fever Endocarditis and C. burnetii Infections in Greece

Coxiella burnetii, the bacteria that cause Q fever. Credit: NIAID

A new paper in the journal Emerging Infectious Diseases finds serologic evidence of C. burnetii infection throughout Greece and identifies a new C. burnetii genotype in the aortic valve of a patient with Q fever endocarditis.

Q fever is a worldwide zoonosis caused by an obligate intracellular bacterium, Coxiella burnetii. Although the classification of C. burnetii by the U.S. Centers for Disease Control and Prevention as a potential bioterrorism agent resulted in the disease becoming reportable in many countries, Q fever is not considered a public health problem in Greece, and few cases have been recorded.

Preliminary data show that physicians in Greece are not as familiar with Q fever because most of the suspected cases were in patients without bovine contact. C. burnetii infection is suspected mostly in culture-negative serious endocarditis case-patients. Recently, it was found that C. burnetii genotype 32 is circulating in sheep and goat in 8 different areas of Greece. The clinical manifestations of Q fever depend, at least in part, on the C. burnetii genotype. However, although acute clinical manifestations are strain-specific, all genotypes have been associated with endocarditis.

Q Fever Endocarditis and a New Genotype of Coxiella burnetii, Greece. Emerging Infectious Diseases. Volume 26, Number 10, October 2020, Early Release September 07, 2020.

Tags: Editor PickEpidemiologyQ FeverSelect Agents

Related Posts

Medical Countermeasures

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
Load More

Latest News

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC